|
Potent HCV Diamidate Pronucleotide Inhibitors: In Vitro Antiviral Activity Optimization (Idenix)
|
|
|
Reported by Jules Levin
Presented at the XXth IRT - 05-09th Aug. 2012 - Montreal, Canada
C.B. Dousson*, C. Parsy, K. Gupta, B. Hernandez-Santiago, J.-L. Paparin, C. Pierra, D. Dukhan, A. Roland, M. La Colla, N. Golitsina, M. Seifer, G. Gosselin & D. Surleraux
Idenix Pharmaceuticals, Inc., Cambridge, MA, USA and Montpellier, France
![HCV1.gif](../images/020113/020113-1/HCV1.gif)
![HCV2.gif](../images/020113/020113-1/HCV2.gif)
![HCV3.gif](../images/020113/020113-1/HCV3.gif)
![HCV4.gif](../images/020113/020113-1/HCV4.gif)
![HCV5.gif](../images/020113/020113-1/HCV5.gif)
|
|
|
|
|
|
|